Gerd Mikus

10.7k citations

254 papers · 7.9k indexed · h-index 53

Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism 94
- Antibiotics Pharmacokinetics and Efficacy 45
- Drug-Induced Hepatotoxicity and Protection 14
Anesthesiology and Pain Medicine top 0.2%
- Pain Management and Opioid Use 18
Toxicology top 0.5%
Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 94
- Antibiotics Pharmacokinetics and Efficacy 45
- Drug-Induced Hepatotoxicity and Protection 14
Pediatrics, Perinatology and Child Health top 0.5%
- Pharmacological Effects and Toxicity Studies 52
Oncology
- Drug Transport and Resistance Mechanisms 35
Infectious Diseases
- Antifungal resistance and susceptibility 25
Psychiatry and Mental health
- Epilepsy research and treatment 21

Co-authors: Walter E. Haefeli Jürgen Burhenne Michel Eichelbaum Johanna Weiß Ute Hofmann Nicolas Hohmann Klaus‐Dieter Riedel Klaus Eckhardt
Cited by: Pharmacology Anesthesiology and Pain Medicine Toxicology
Journals: British Journal of Clinical Pharmacology (31 papers)Clinical Pharmacology & Therapeutics (19 papers)European Journal of Clinical Pharmacology (19 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Gerd Mikus

247 papers receiving 7.6k citations

Peers

Countries citing papers authored by Gerd Mikus

Since Specialization

Citations

This map shows the geographic impact of Gerd Mikus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerd Mikus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerd Mikus more than expected).

Fields of papers citing papers by Gerd Mikus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerd Mikus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerd Mikus. The network helps show where Gerd Mikus may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gerd Mikus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerd Mikus Line = papers co-authored together Gerd Mikus links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effect of the frequently used antiepileptic drugs carbamazepine, gabapentin, and pregabalin on the pharmacokinetics of edoxaban and other oral factor xa inhibitors in healthy volunteers Frontiers in Pharmacology ·Seunghun Han,ZENG Deqiang,康司許斐,Jürgen Burhenne,Kathrin I. Foerster,David Czock,Gerd Mikus,Andreas D. Meid,Walter E. Haefeli,Antje Blank	2025	0
2	Understanding Voriconazole Metabolism: A Middle-Out Physiologically-Based Pharmacokinetic Modelling Framework Integrating In Vitro and Clinical Insights Clinical Pharmacokinetics ·Toni Sculac,Francisco José Ramiro de la Mata,Joyce Ann Clayton,Charles F. Landenberger,A. Konrad,Alex Alta Tierra,Gerd Mikus,Wilhelm Huisinga,Charlotte Kloft,Robin Michelet	2024	0
3	Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers Clinical Pharmacokinetics ·Bao-Qu Zhang,大亀浩久,Kathrin I. Foerster,Jürgen Burhenne,Martin Schulz,Antje Blank,Gerd Mikus,Walter E. Haefeli	2024	2
4	Dose‐dependent induction of CYP3A activity by St. John's wort alone and in combination with rifampin Clinical and Translational Science ·Nicolas Hohmann,政夫斎藤,Jürgen Burhenne,Antje Blank,Gerd Mikus,Walter E. Haefeli	2024	7
5	Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers Frontiers in Pharmacology ·L. M. Neekers,Jürgen Burhenne,Johanna Weiß,Mathias Haag,Ute Hofmann,Matthias Schwab,Stephan Urban,Gerd Mikus,David Czock,Walter E. Haefeli,Antje Blank	2023	4
6	Frailty as a Marker for the Plasma Concentrations of Direct Oral Anticoagulants in Older Patients: Results of an Exploratory Study Drugs & Aging ·Салимгареева Н. Р.,Christina Grabow,Petra Benzinger,Kathrin I. Foerster,Jürgen Burhenne,David Czock,康司許斐,Antje Blank,Gerd Mikus,Walter E. Haefeli,Jürgen M. Bauer	2023	1
7	Time course of CYP3A activity during and after metamizole (dipyrone) in healthy volunteers British Journal of Clinical Pharmacology ·郭惠丽,大亀浩久,Lenka A. Taylor,허정우,Torsten Hoppe‐Tichy,Jürgen Burhenne,Kathrin I. Foerster,Markus Dachtler,Gerald Huber,Joel Gomes Baptista,Towarzystwo Kultury Polskiej im Kościuszki,David Czock,Gerd Mikus,Antje Blank,Walter E. Haefeli	2023	8
8	Evaluation of CYP2C19 activity using microdosed oral omeprazole in humans European Journal of Clinical Pharmacology ·María José Pareja,Kathrin I. Foerster,Antje Blank,Peter W. Rose,Jürgen Burhenne,Walter E. Haefeli,Gerd Mikus	2022	4
9	Perpetrator Characteristics of Azole Antifungal Drugs on Three Oral Factor Xa Inhibitors Administered as a Microdosed Cocktail Clinical Pharmacokinetics ·Bao-Qu Zhang,Kathrin I. Foerster,Antje Blank,Jürgen Burhenne,Amed Ramírez-Sánchez,Walter E. Haefeli,Gerd Mikus	2021	10
10	Perspectives on Model‐Informed Precision Dosing in the Digital Health Era: Challenges, Opportunities, and Recommendations Clinical Pharmacology & Therapeutics ·Alex Alta Tierra,Robin Michelet,名取早苗,Françoise Gray,YU Zhibin,Madelé van Dyk,Gerd Mikus,Wilhelm Huisinga,Charlotte Kloft	2020	52
11	Midazolam microdosing applied in early clinical development for drug–drug interaction assessment British Journal of Clinical Pharmacology ·Sabrina Wiebe,A. Di Stasio,Inyoo Kim,Lonica Andreea,Alen Jambrecina,Armin Schultz,Richard Vinisko,M. Wang,Lena Herich,Gerd Mikus	2020	10
12	Drug–Drug Interactions with Direct Oral Anticoagulants Clinical Pharmacokinetics ·Kathrin I. Foerster,ZENG Deqiang,Gerd Mikus,Walter E. Haefeli	2020	80
13	Simultaneous quantification of the CYP2D6 substrate yohimbine, its metabolite 11-OH-yohimbine, and the CYP2D6 inhibitor paroxetine in human plasma Analytical Methods ·No A.S. Sijben,Gisela Skopp,Gerd Mikus,Jürgen Burhenne	2019	1
14	A follow-up report on potential drug interactions with clementines: Two single case experiments show no effect on CYP3A-dependent midazolam clearance European Journal of Pharmaceutical Sciences ·Nicolas Hohmann,Gerd Mikus,Walter E. Haefeli,Vedat Schwenger,Giuseppe Gattuso,Davide Barreca,Johanna Weiß	2019	4
15	Simultaneous phenotyping of CYP2E1 and CYP3A using oral chlorzoxazone and midazolam microdoses British Journal of Clinical Pharmacology ·Nicolas Hohmann,Antje Blank,Jürgen Burhenne,Yosuke Suzuki,Gerd Mikus,Walter E. Haefeli	2019	13
16	Microdosed Cocktail of Three Oral Factor Xa Inhibitors to Evaluate Drug–Drug Interactions with Potential Perpetrator Drugs Clinical Pharmacokinetics ·Gerd Mikus,Kathrin I. Foerster,Storage from Source to Eruption Site,Marie‐Louise Lehmann,Jürgen Burhenne,Walter E. Haefeli	2019	11
17	Autoinhibitory properties of the parent but not of the N‐oxide metabolite contribute to infusion rate‐dependent voriconazole pharmacokinetics British Journal of Clinical Pharmacology ·Nicolas Hohmann,Ireen Haque,Antje Blank,Johanna Weiß,Jürgen Burhenne,Walter E. Haefeli,Gerd Mikus	2017	19
18	Vorinostat in refractory soft tissue sarcomas – Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO) European Journal of Cancer ·Thomas Schmitt,Regine Mayer‐Steinacker,Frank Mayer,Viktor Grünwald,J. Schütte,Jörg T. Hartmann,Bernd Kasper,Johannes Hüsing,Jacek Hajda,L Janko,Gunhild Mechtersheimer,Gerd Mikus,Jürgen Burhenne,Lorenz Lehmann,Christoph E. Heilig,Anthony D. Ho,Gerlinde Egerer	2016	32
19	Chronopharmacology of intravenous and oral modified release verapamil British Journal of Clinical Pharmacology ·Karin Dilger,Klaus Eckhardt,Ute Hofmann,Klaus Kucher,Gerd Mikus,Michel Eichelbaum	1999	25
20	Interaction of verapamil and cimetidine: stereochemical aspects of drug metabolism, drug disposition and drug action. Journal of Pharmacology and Experimental Therapeutics ·Gerd Mikus,Michel Eichelbaum,Christine Fischer,S. W. Gumułka,Ulrich Klotz,H K Kroemer	1990	57

About Gerd Mikus

Gerd Mikus is a scholar working on Pharmacology, Anesthesiology and Pain Medicine, Pharmacology, Pediatrics, Perinatology and Child Health and Toxicology, having authored 254 papers that have together received 7.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (94 papers), Pharmacological Effects and Toxicity Studies (52 papers), Antibiotics Pharmacokinetics and Efficacy (45 papers), Drug Transport and Resistance Mechanisms (35 papers), Antifungal resistance and susceptibility (25 papers), Epilepsy research and treatment (21 papers), Pain Management and Opioid Use (18 papers) and Drug-Induced Hepatotoxicity and Protection (14 papers). The work is most often cited by research in Pharmacology (2.4k citations), Anesthesiology and Pain Medicine (854 citations), Toxicology (265 citations), Pharmacology (1.3k citations) and Pediatrics, Perinatology and Child Health (1.5k citations). Gerd Mikus has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Walter E. Haefeli, Jürgen Burhenne, Michel Eichelbaum, Johanna Weiß, Ute Hofmann, Nicolas Hohmann, Klaus‐Dieter Riedel, Klaus Eckhardt, I. Walter‐Sack and Susanne Ammon. Their work appears in journals such as British Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, European Journal of Clinical Pharmacology, Clinical Pharmacokinetics and The Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact